Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002009620 | SCV002304698 | uncertain significance | Arrhythmogenic right ventricular dysplasia 10 | 2021-08-05 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with DSG2-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with valine at codon 588 of the DSG2 protein (p.Leu588Val). The leucine residue is highly conserved and there is a small physicochemical difference between leucine and valine. |
Color Diagnostics, |
RCV003533092 | SCV004363201 | uncertain significance | Cardiomyopathy | 2022-08-17 | criteria provided, single submitter | clinical testing | This missense variant replaces leucine with valine at codon 588 of the DSG2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 1/249162 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
All of Us Research Program, |
RCV004011128 | SCV004819569 | uncertain significance | Arrhythmogenic right ventricular cardiomyopathy | 2022-10-25 | criteria provided, single submitter | clinical testing | This missense variant replaces leucine with valine at codon 588 of the DSG2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 1/249162 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |